Course of neuromyelitis optica during inadvertent pregnancy in a patient treated with rituximab

Abstract

In neuromyelitis optica (NMO), the monoclonal B-cell antibody rituximab is a therapeutic option. Little is known about the course of NMO and the safety of rituximab during pregnancy. In this study, we report the clinical course of a patient with NMO after application of rituximab 1 week before inadvertent conception. Mother and child did not experience any adverse event, and the postpartum development of the baby was completely normal up to 15 months. Clinical course of NMO was stable during the entire pregnancy. This case illustrates a favorable outcome in a pregnant NMO patient and her child after therapy with rituximab.

Keywords

devic’s disease neuromyelitis optica pregnancy rituximab

Get full access to this article

View all access options for this article.

References

1 Jacob A; Weinshenker BG; Violich I; . Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Arch Neurol 2008; 65: 1443–1448.

2 Friedrichs B Tiemann M Salwender H Verpoort K Wenger MK Schmitz N . The effects of rituximab treatment during pregnancy on a neonate. Haematologica 2006; 91: 1426–1427.

3 Wingerchuk DM Hogancamp WF O'Brien PC Weinshenker BG . The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999; 53: 1107–1114.

4 Cornelio DB Braga RP Rosa MW Ayub AC . Devic's neuromyelitis optica and pregnancy: distinction from multiple sclerosis is essential. Arch Gynecol Obstet 2009 [Epub ahead of print].

5 Wegmann TG Lin H Guilbert L Mosmann TR . Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon. Immunol Today 1993; 14: 353–356 [Review].

6 Achiron A Kishner I Dolev M . Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis. J Neurol 2004; 251: 1133–1137.

7 Confavreux C Hutchinson M Hours MM Cortinovis-Tourniaire P Moreau T . Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in multiple sclerosis group. N Engl J Med 1998; 339: 285–291.

8 Keeling SO Oswald AE . Pregnancy and rheumatic disease: ‘‘by the book’’ or ‘‘by the doc’’. Clin Rheumatol 2009; 28: 1–9.

9 Tincani A Rebaioli CB Frassi M . Pregnancy Study Group of Italian Society of Rheumatology. Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome. Autoimmun Rev 2005; 4: 423–428 [Review].

10.

10 Cohen JA . How effective is intravenous immunoglobulin for the treatment of relapsing-remitting multiple sclerosis. Nat Clin Pract Neurol 2008; 4: 588–589 Epub 2008 Oct 14.